European trials with total mesorectal excision

Seminars in Surgical Oncology

Volumn 19, Issue 4, 2000, Pages 350-357

  Kapiteijn, Ellen ^a   Van De Velde, Cornelis J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinical trials; Colorectal surgery; Phase III; Rectal neoplasms

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; HUMAN; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY CONTROL; RECTUM CANCER; RECTUM SURGERY; REVIEW;

CLINICAL TRIALS; EUROPE; HUMANS; LYMPH NODE EXCISION; RECTAL NEOPLASMS; RECTUM;

EID: 0034472970     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.5     Document Type: Review

References (44)

1. Local recurrence in patients with rectal cancer, diagnosed between 1988 and 1992: A population-based study in the west Netherlands
2. Radical abdominopelvic lymphadenectomy: Historic perspective and current role in the surgical management of rectal cancer
3. Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture
4. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum
5. Female sexual functioning after radical surgical treatment of rectal and bladder cancer
6. Morbidity and mortality following abdominoperineal resection for rectal adenocarcinoma
7. Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish Rectal Cancer Trial
8. Potency, cure, and local control in the operative treatment of rectal cancer
9. Results of radical surgery for rectal cancer
10. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm
11. Total mesorectal excision in the operative treatment of carcinoma of the rectum
12. Radical and nerve-preserving surgery for rectal cancer in the Netherlands: A prospective study on morbidity and functional outcome
13. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial
14. Adjuvant 5FU plus Levamisole improves survival in stage II and Ill colonic cancer, but not in rectal cancer, Interim analysis of the Netherlands Adjuvant Colorectal Cancer Project (NACCP)
15. Adjuvant therapy for patients with colon and rectal cancer
16. Adjuvant radiation therapy for rectal carcinoma: Predictors of outcome
17. Impact of variability among surgeons on post-operative morbidity and mortality and ultimate survival
18. Prognostic factors of rectum carcinoma - Experience of the German Multicentre Study SGCRC
19. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination
20. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision
21. The pathologist's role in the assessment of local recurrence in rectal carcinoma
22. Total mesorectal excision is optimal surgery for rectal cancer: A Scandinavian consensus
23. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer
24. Total mesorectal excision (TME) with or without preoperative radiotherapy (RT) in the treatment of primary rectal carcinoma
25. Pathology data in the central databases of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers
26. Improved survival in patients with rectal cancer: A population-based register study
27. Adjuvant and neoadjuvant radiochemotherapy for advanced rectal cancer - First results of the German multicenter phase-III-trial (Protocol CAO/ARO/AIO 94)
28. Workshop of the EORTC Radiotherapy Group on quality assurance in cooperative trials of radiotherapy: A recommendation for EORTC Cooperative Groups
29. Preoperative radiotherapy as adjuvant treatment in rectal cancer
30. Local recurrence and survival in patients with rectal cancer, diagnosed 1981-86: A community hospital-based study in the south-east Netherlands
31. Prolongation of the disease-free interval in surgically treated rectal carcinoma
32. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01
33. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer
34. The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial
35. Carcinoma of the rectum. Profiles of intraoperative and early postoperative complications
36. Risk of peritonitis and fatal septicaemia and the need to defunction the low anastomosis
37. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer
38. Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma
39. Mortality, morbidity, and patterns of recurrence after abdominoperineal resection for cancer of the rectum
40. Aetiology of disruption of intestinal anastomoses
41. Carcinoma of the rectum and the rectosigmoid. A review of 729 cases
42. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection
43. The future of external beam irradiation as initial treatment of rectal cancer
44. Postoperative radiotherapy in Dukes B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study